🇺🇸 Octaplex in United States

67 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 67

Most-reported reactions

1. Drug Interaction — 9 reports (13.43%)
2. Syncope — 9 reports (13.43%)
3. Haematemesis — 8 reports (11.94%)
4. Bradycardia — 7 reports (10.45%)
5. Dyspnoea — 7 reports (10.45%)
6. Subdural Haematoma — 7 reports (10.45%)
7. Cardiac Arrest — 5 reports (7.46%)
8. Cardio-Respiratory Arrest — 5 reports (7.46%)
9. Haematuria — 5 reports (7.46%)
10. Haemoglobin Decreased — 5 reports (7.46%)

Source database →

Frequently asked questions

Is Octaplex approved in United States?

Octaplex does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Octaplex in United States?

Octapharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.